Loading: 100%
Cardiovascular Systems Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 579 (as per FY 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker CSIIno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 172024283236
datesClosing price (adj.)
13.10.201727.75
11.10.201728.49
04.10.201729.26
27.09.201728.37
20.09.201727.25
13.09.201730.62
06.09.201729.73
30.08.201729.15
23.08.201728.93
16.08.201730.46
09.08.201730.59
02.08.201730.78
26.07.201732.21
19.07.201732.68
12.07.201732.00
05.07.201732.84
27.06.201730.33
20.06.201731.61
13.06.201730.83
06.06.201730.80
30.05.201730.04
23.05.201731.10
16.05.201732.47
09.05.201730.01
02.05.201730.22
25.04.201729.68
18.04.201728.11
11.04.201728.98
04.04.201728.78
28.03.201728.29
21.03.201726.21
14.03.201726.74
07.03.201726.80
28.02.201728.40
21.02.201728.17
14.02.201728.05
07.02.201726.34
31.01.201724.70
24.01.201725.73
17.01.201725.71
10.01.201724.61
03.01.201724.11
27.12.201625.02
19.12.201625.63
12.12.201625.49
05.12.201623.85
28.11.201624.72
21.11.201626.39
14.11.201624.95
07.11.201623.67
31.10.201623.43
24.10.201623.32
17.10.201624.40
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
27.75n/a
Market Capitalisation
in million USD
910n/a
Enterprise Value
in million USD
849n/a
Common Shares Outstanding
as per Jun 30, 2016
32,792,497n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
32,537,621n/a
Average Diluted Shares Outstanding
TTM
32,537,621n/a
Index Membership
n/a
Business Summary
Cardiovascular Systems Inc is a medical technology company developing solutions for vascular and coronary disease. It treats patients suffering from peripheral and coronary artery diseases, including those with arterial calcium.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 178n/a
Gross Profit 143n/a
Operating Income -46n/a
EBITDA -42n/a
Net Profit -56n/a
Balance Sheet
Cash and Cash Equivalents 61n/a
Receivables 23n/a
Total Current Assets 105n/a
PP&E 32n/a
Total Assets 142n/a
Accounts Payable 9n/a
Current Debt 0n/a
Total Current Liabilities 35n/a
Long-Term Debt 0n/a
Total Liabilities 42n/a
Total Equity 101n/a
Cash Flow
Depreciation & Amortisation 4n/a
Change in Working Capital 14n/a
Operating Cash Flow -24n/a
Net Change in PP&E and Intangibles -5n/a
Investing Cash Flow -4n/a
Dividends Paid 0n/a
Financing Cash Flow 4n/a
Total Change in Cash -23n/a
Free Cash Flow -32n/a
Profitability Ratios
Gross Margin 80.1%n/a
Operating Margin -25.7%n/a
Net Profit Margin -31.4%n/a
Return on Equity -55.5%n/a
Return on Assets -39.3%n/a
Per Share Figures
Basic EPS -1.72n/a
Diluted EPS -1.72n/a
Sales per Share 5.48n/a
Book Value per Share 3.10n/a
FCF per Share -0.98n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -16.12n/a
Price to Sales Ratio 5.07n/a
Price to Book Value 8.95n/a
Price to Free Cash Flow -28.27n/a
Valuation Metrics
EV/EBITDA -20.31n/a
EV/Sales 4.76n/a
Book to Market Value 0.11n/a
Other Ratios
Current Ratio 295.5%n/a
Liabilities to Equity Ratio 41.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
65
79
82
104
137
182
178
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-15
-16
-19
-24
-31
-40
-35
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
50
63
63
80
106
142
143
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-73
-71
-78
-102
-139
-175
-188
Selling, General & Administrative
-62
-62
-66
-87
-118
-144
-163
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-10
-9
-11
-15
-21
-31
-26
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-23
-9
-14
-22
-33
-33
-46
Non-Operating Income (Loss)
-1
-2
-2
-2
-2
0
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
-2
-2
-2
-2
0
0
Pretax Income (Loss), Adjusted
-24
-11
-17
-24
-35
-33
-46
Abnormal Gains (Losses)
0
0
0
0
0
0
-10
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-24
-11
-17
-24
-35
-33
-56
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-24
-11
-17
-24
-35
-33
-56
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-24
-11
-17
-24
-35
-33
-56
Minority Interest
0
0
0
0
0
0
0
Net Income
-24
-11
-17
-24
-35
-33
-56
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-24
-11
-17
-24
-35
-33
-56
Remarks
restated on Sep 10, 2012 n/a
calculated values,
restated on Sep 11, 2013 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Aug 27, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
21
36
68
127
86
61
Cash & Cash Equivalents
n/a
21
36
68
127
84
61
Short Term Investments
n/a
0
0
0
0
2
1
Accounts & Notes Receivable
n/a
13
14
15
21
31
23
Accounts Receivable, Net
n/a
13
14
15
21
31
23
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
6
7
6
13
14
17
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
1
2
1
2
3
3
Prepaid Expenses
n/a
1
2
1
2
3
3
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
41
58
90
163
134
105
Property, Plant & Equipment, Net
n/a
2
2
3
15
33
32
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
3
3
4
4
5
5
Intangible Assets
n/a
2
3
3
4
5
5
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1
1
1
0
0
0
Total Noncurrent Assets
n/a
6
5
7
19
37
38
Total Assets
n/a
47
63
97
182
171
142
Liabilities and owners' equity
Payables & Accruals
n/a
11 10726000
13 12872000
17 17318000
27 27329000
30 29888000
35 35499000
Accounts Payable
n/a
5 5181000
6 5610000
7 7230000
10 9703000
10 9763000
9 8506000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
6 5545000
7 7262000
10 10088000
18 17626000
20 20125000
27 26993000
Short Term Debt
n/a
4 3813000
5 4678000
5 5095000
2 2400000
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1 647000
0 302000
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
1 647000
0 302000
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
15 15186000
18 17852000
22 22413000
30 29729000
30 29888000
35 35499000
Long Term Debt
n/a
8 8331000
13 12842000
7 7472000
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2 1606000
0 241000
0 180000
0 117000
2 2005000
6 6010000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
2 1606000
0 241000
0 180000
0 117000
2 2005000
6 6010000
Total Noncurrent Liabilities
n/a
10 9937000
13 13083000
8 7652000
0 117000
2 2005000
6 6010000
Total Liabilities
n/a
25 25123000
31 30935000
30 30065000
30 29846000
32 31893000
42 41509000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
184 184083000
211 211427000
270 270107000
391 390620000
411 410732000
428 428268000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-162 -162448000
-179 -179238000
-203 -203275000
-239 -238565000
-271 -271387000
-327 -327411000
Other Equity
n/a
0 0
0 0
0 0
0 0
0 90000
0 40000
Equity Before Minority Interest
n/a
22 21635000
32 32189000
67 66832000
152 152055000
139 139435000
101 100897000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
22 21635000
32 32189000
67 66832000
152 152055000
139 139435000
101 100897000
Total Liabilities & Equity
n/a
47 46758000
63 63124000
97 96897000
182 181901000
171 171328000
142 142406000
Remarks restated on n/a restated on Sep 10, 2012 n/a restated on Sep 11, 2013 n/a restated on Aug 28, 2014 n/a restated on Aug 27, 2015 n/a restated on Aug 25, 2016 n/a restated on Aug 25, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-24
-11
-17
-24
-35
-33
-56
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
1
1
1
1
1
2
4
Non-Cash Items
9
7
6
8
12
16
14
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
0
-5
-1
4
-5
-8
14
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-14
-8
-11
-11
-27
-22
-24
Change in Fixed Assets & Intangibles
-1
-2
-1
-2
-13
-21
-5
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
-2
1
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
23
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
22
-2
-1
-2
-13
-23
-4
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-19
5
6
0
-5
-2
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
1
1
16
40
88
3
3
Increase in Capital Stock
1
1
16
40
88
3
3
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
2
4
6
16
2
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-18
8
27
46
99
3
4
Net Cash Before Disc. Operations and FX
-10
-3
14
32
59
-43
-23
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-10
-3
14
32
59
-43
-23
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
-10
-3
14
32
59
-43
-23
Remarks
restated on Sep 10, 2012 n/a
calculated values,
restated on Sep 11, 2013 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Aug 27, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo